Radiopharm Theranostics (RADX)

• Market cap: $32.8M
• 1 day: 4%
• 5 days: -7.96%
• 1 month: -7.35%
• 3 months: -16.8%
• 6 months: -11.11%
• Year to date: -19.38%
• 1 year: 2.46%
• 5 years: -76.46%
• 10 years: -76.46%
• Sector: Healthcare
• Industry: Biotechnology

About: Radiopharm Theranostics Ltd is an Australian-based clinical-stage radiotherapeutics company targeting cancer. The company has a pipeline of approximately four licensed platform technologies, with diagnostic and therapeutic applications at both the pre-clinical and clinical stages of development. The company is engaged in research, development, and commercialization of health technologies.

Employees: 14